Remove Engineering Remove Protein Expression Remove Therapies
article thumbnail

SRC-3: CoRegen’s revolutionary approach to cancer

Drug Target Review

This interview explores how CoRegen’s innovative techniques are not only transforming cancer treatment but also hold promise for a wide range of medical applications, all while minimising the side effects often associated with traditional therapies. What are the key benefits of your approach?

article thumbnail

Spirulina’s role in shaping the future of preventative biologics

Drug Target Review

Spirulina, an edible photosynthetic microbe, offers an innovative way to produce therapeutic proteins such as antibodies or enzymes directly inside the organism. The ability to engineer spirulina in this way offers significant advantages in terms of manufacturing costs and scalability. Its simple in principle.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management

LifeSciVC

This concept of effecting a protein change. was based on experience building on the understanding that a single protein variant, could have markedly different outcomes for patients with chronic kidney disease. We built our proprietary OPERA platform ( here ), leveraging oligonucleotide guided RNA editing to modulate protein expression.

RNA 68
article thumbnail

Women in Stem with Dr Beate Mueller-Tiemann

Drug Target Review

A pivotal moment for me was when I realised that if I understood disease mechanisms on a molecular level, I could be part of an industry that helps develop medicines/therapies for those who need them most. Beate is an elected member of the Board of the Dechema, German Society for Chemical Engineering and Biotechnology.

article thumbnail

Biopharma Money on the Move: December 2 – 8

The Pharma Data

Since partnering with Eli Lilly to produce the first monoclonal antibody therapy approved for mild-to-moderate COVID-19 patients, antibody discovery company AbCellera is going big on the Nasdaq. The engineered cells are protected by Sigilon’s Afibromer biomaterials matrix, which shields them from immune rejection and fibrosis.

RNA 52
article thumbnail

Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study

The Pharma Data

The vaccine candidate, presently at a preclinical development stage, is a non-chemically modified mRNA, encoding the prefusion stabilized full-length spike protein of the SARS-CoV-2 virus, and formulated within Lipid Nanoparticles (LNPs). CureVac had its initial public offering on the New York Nasdaq in August 2020.

article thumbnail

Five Promising Treatment Areas in Early-Phase Drug Development in 2024

Alta Sciences

Psychedelics Psychedelic therapy (or psychedelic-assisted therapy) refers to the use of psychedelic drugs, such as psilocybin, MDMA, LSD, ketamine, and ayahuasca, to treat mental disorders, especially those that have no effective treatments available or are treatment resistant.